Molecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction

Melanocortin-3 receptor (MC3R), primarily expressed in the hypothalamus, plays an important role in the regulation of energy homeostasis. MC3R-deficient (MC3R -/-) mice demonstrate increased fat mass, higher feeding efficiency, hyperleptinaemia, and mild hyperinsulinism. At least one specific mutati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2006-01, Vol.45 (4), p.1128-1137
Hauptverfasser: Chen, Min, Aprahamian, Charles J, Celik, Ahmet, Georgeson, Keith E, Garvey, W. Timothy, Harmon, Carroll M, Yang, Yingkui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1137
container_issue 4
container_start_page 1128
container_title Biochemistry (Easton)
container_volume 45
creator Chen, Min
Aprahamian, Charles J
Celik, Ahmet
Georgeson, Keith E
Garvey, W. Timothy
Harmon, Carroll M
Yang, Yingkui
description Melanocortin-3 receptor (MC3R), primarily expressed in the hypothalamus, plays an important role in the regulation of energy homeostasis. MC3R-deficient (MC3R -/-) mice demonstrate increased fat mass, higher feeding efficiency, hyperleptinaemia, and mild hyperinsulinism. At least one specific mutation of MC3R has been identified to be associated with human obesity. Functional analysis of this altered MC3R (I183N) has indicated that the mutation completely abolishes agonist-mediated receptor activation. However, the specific molecular determinants of MC3R responsible for ligand binding and receptor signaling are currently unknown. The present study is to determine the structural aspects of MC3R responsible for ligand binding and receptor signaling. On the basis of our theoretical model for MC1R, using mutagenesis, we have examined 19 transmembrane domain amino acids selected for these potential roles in ligand binding and receptor signaling. Our results indicate that (i) substitutions of charged amino acid residues E131 in transmembrane domain 2 (TM2), D154 and D158 in TM3, and H298 in TM6 with alanine dramatically reduced NDP-MSH binding affinity and receptor signaling, (ii) substitutions of aromatic amino acids F295 and F296 in TM6 with alanine also significantly decreased NDP-MSH binding and receptor activity, (iii) substitutions of D121in TM2 and D332 in TM7 with alanine resulted in the complete loss of ligand binding, ligand induced receptor activation, and cell surface protein expression, and (iv) interestingly, substitution of L165 in TM3 with methionine or alanine switched antagonist SHU9119 into a receptor agonist. In conclusion:  Our results suggest that TM3 and TM6 are important for NDP-MSH binding, while D121 in TM2 and D332 in TM7 are crucial for receptor activity and signaling. Importantly, L165 in TM3 is critical for agonist or antagonist selectivity. These results provide important information about the molecular determinants of hMC3R responsible for ligand binding and receptor signaling.
doi_str_mv 10.1021/bi0521792
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_bi0521792</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c663230359</sourcerecordid><originalsourceid>FETCH-LOGICAL-a351t-5f8023f92a12716e090ba32d782c889746888e345d07b6570bd69aba8322138c3</originalsourceid><addsrcrecordid>eNptkE1OwzAQhS0EoqWw4AIoGxYsAmM78c8SVZRWagSCgkQ3luM4kNImlZNIwAlYc0ROglGqsmE1mpnvvdE8hI4xnGMg-CItICaYS7KD-jgmEEZSxruoDwAsJJJBDx3U9cK3EfBoH_UwiygQkH30lFRLa9qldsHwRTttGuuKD90UVRlUeTBuV7oMErvUZWUq1xRlSIM7a-y6qVwwLZ51mX1_fm0nk9LrvYmXH6K9XC9re7SpA_QwupoNx-H05noyvJyGmsa4CeNcAKG5JBoTjpkFCammJOOCGCEkj5gQwtIozoCnLOaQZkzqVAtKCKbC0AE663yNq-ra2VytXbHS7l1hUL_xqG08nj3p2HWbrmz2R27y8EDYAUXd2LftXrtXxTjlsZrd3qvkMZmP2YipuedPO16bWi2q1pX-1X8O_wCwL3ru</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Molecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Chen, Min ; Aprahamian, Charles J ; Celik, Ahmet ; Georgeson, Keith E ; Garvey, W. Timothy ; Harmon, Carroll M ; Yang, Yingkui</creator><creatorcontrib>Chen, Min ; Aprahamian, Charles J ; Celik, Ahmet ; Georgeson, Keith E ; Garvey, W. Timothy ; Harmon, Carroll M ; Yang, Yingkui</creatorcontrib><description>Melanocortin-3 receptor (MC3R), primarily expressed in the hypothalamus, plays an important role in the regulation of energy homeostasis. MC3R-deficient (MC3R -/-) mice demonstrate increased fat mass, higher feeding efficiency, hyperleptinaemia, and mild hyperinsulinism. At least one specific mutation of MC3R has been identified to be associated with human obesity. Functional analysis of this altered MC3R (I183N) has indicated that the mutation completely abolishes agonist-mediated receptor activation. However, the specific molecular determinants of MC3R responsible for ligand binding and receptor signaling are currently unknown. The present study is to determine the structural aspects of MC3R responsible for ligand binding and receptor signaling. On the basis of our theoretical model for MC1R, using mutagenesis, we have examined 19 transmembrane domain amino acids selected for these potential roles in ligand binding and receptor signaling. Our results indicate that (i) substitutions of charged amino acid residues E131 in transmembrane domain 2 (TM2), D154 and D158 in TM3, and H298 in TM6 with alanine dramatically reduced NDP-MSH binding affinity and receptor signaling, (ii) substitutions of aromatic amino acids F295 and F296 in TM6 with alanine also significantly decreased NDP-MSH binding and receptor activity, (iii) substitutions of D121in TM2 and D332 in TM7 with alanine resulted in the complete loss of ligand binding, ligand induced receptor activation, and cell surface protein expression, and (iv) interestingly, substitution of L165 in TM3 with methionine or alanine switched antagonist SHU9119 into a receptor agonist. In conclusion:  Our results suggest that TM3 and TM6 are important for NDP-MSH binding, while D121 in TM2 and D332 in TM7 are crucial for receptor activity and signaling. Importantly, L165 in TM3 is critical for agonist or antagonist selectivity. These results provide important information about the molecular determinants of hMC3R responsible for ligand binding and receptor signaling.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi0521792</identifier><identifier>PMID: 16430209</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>alpha-MSH - analogs &amp; derivatives ; alpha-MSH - chemistry ; alpha-MSH - metabolism ; Amino Acid Sequence ; Amino Acid Substitution - genetics ; Amino Acid Substitution - physiology ; Amino Acids, Aromatic - genetics ; Amino Acids, Aromatic - metabolism ; Humans ; Kinetics ; Ligands ; Melanocyte-Stimulating Hormones - metabolism ; Melanocyte-Stimulating Hormones - pharmacology ; Membrane Proteins - metabolism ; Models, Biological ; Models, Molecular ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Protein Binding - genetics ; Protein Binding - physiology ; Protein Structure, Tertiary - genetics ; Receptor, Melanocortin, Type 3 - antagonists &amp; inhibitors ; Receptor, Melanocortin, Type 3 - chemistry ; Receptor, Melanocortin, Type 3 - genetics ; Receptor, Melanocortin, Type 3 - metabolism ; Receptors, Peptide - metabolism ; Signal Transduction ; Transfection</subject><ispartof>Biochemistry (Easton), 2006-01, Vol.45 (4), p.1128-1137</ispartof><rights>Copyright © 2006 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a351t-5f8023f92a12716e090ba32d782c889746888e345d07b6570bd69aba8322138c3</citedby><cites>FETCH-LOGICAL-a351t-5f8023f92a12716e090ba32d782c889746888e345d07b6570bd69aba8322138c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi0521792$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi0521792$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16430209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Min</creatorcontrib><creatorcontrib>Aprahamian, Charles J</creatorcontrib><creatorcontrib>Celik, Ahmet</creatorcontrib><creatorcontrib>Georgeson, Keith E</creatorcontrib><creatorcontrib>Garvey, W. Timothy</creatorcontrib><creatorcontrib>Harmon, Carroll M</creatorcontrib><creatorcontrib>Yang, Yingkui</creatorcontrib><title>Molecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Melanocortin-3 receptor (MC3R), primarily expressed in the hypothalamus, plays an important role in the regulation of energy homeostasis. MC3R-deficient (MC3R -/-) mice demonstrate increased fat mass, higher feeding efficiency, hyperleptinaemia, and mild hyperinsulinism. At least one specific mutation of MC3R has been identified to be associated with human obesity. Functional analysis of this altered MC3R (I183N) has indicated that the mutation completely abolishes agonist-mediated receptor activation. However, the specific molecular determinants of MC3R responsible for ligand binding and receptor signaling are currently unknown. The present study is to determine the structural aspects of MC3R responsible for ligand binding and receptor signaling. On the basis of our theoretical model for MC1R, using mutagenesis, we have examined 19 transmembrane domain amino acids selected for these potential roles in ligand binding and receptor signaling. Our results indicate that (i) substitutions of charged amino acid residues E131 in transmembrane domain 2 (TM2), D154 and D158 in TM3, and H298 in TM6 with alanine dramatically reduced NDP-MSH binding affinity and receptor signaling, (ii) substitutions of aromatic amino acids F295 and F296 in TM6 with alanine also significantly decreased NDP-MSH binding and receptor activity, (iii) substitutions of D121in TM2 and D332 in TM7 with alanine resulted in the complete loss of ligand binding, ligand induced receptor activation, and cell surface protein expression, and (iv) interestingly, substitution of L165 in TM3 with methionine or alanine switched antagonist SHU9119 into a receptor agonist. In conclusion:  Our results suggest that TM3 and TM6 are important for NDP-MSH binding, while D121 in TM2 and D332 in TM7 are crucial for receptor activity and signaling. Importantly, L165 in TM3 is critical for agonist or antagonist selectivity. These results provide important information about the molecular determinants of hMC3R responsible for ligand binding and receptor signaling.</description><subject>alpha-MSH - analogs &amp; derivatives</subject><subject>alpha-MSH - chemistry</subject><subject>alpha-MSH - metabolism</subject><subject>Amino Acid Sequence</subject><subject>Amino Acid Substitution - genetics</subject><subject>Amino Acid Substitution - physiology</subject><subject>Amino Acids, Aromatic - genetics</subject><subject>Amino Acids, Aromatic - metabolism</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Ligands</subject><subject>Melanocyte-Stimulating Hormones - metabolism</subject><subject>Melanocyte-Stimulating Hormones - pharmacology</subject><subject>Membrane Proteins - metabolism</subject><subject>Models, Biological</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Protein Binding - genetics</subject><subject>Protein Binding - physiology</subject><subject>Protein Structure, Tertiary - genetics</subject><subject>Receptor, Melanocortin, Type 3 - antagonists &amp; inhibitors</subject><subject>Receptor, Melanocortin, Type 3 - chemistry</subject><subject>Receptor, Melanocortin, Type 3 - genetics</subject><subject>Receptor, Melanocortin, Type 3 - metabolism</subject><subject>Receptors, Peptide - metabolism</subject><subject>Signal Transduction</subject><subject>Transfection</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1OwzAQhS0EoqWw4AIoGxYsAmM78c8SVZRWagSCgkQ3luM4kNImlZNIwAlYc0ROglGqsmE1mpnvvdE8hI4xnGMg-CItICaYS7KD-jgmEEZSxruoDwAsJJJBDx3U9cK3EfBoH_UwiygQkH30lFRLa9qldsHwRTttGuuKD90UVRlUeTBuV7oMErvUZWUq1xRlSIM7a-y6qVwwLZ51mX1_fm0nk9LrvYmXH6K9XC9re7SpA_QwupoNx-H05noyvJyGmsa4CeNcAKG5JBoTjpkFCammJOOCGCEkj5gQwtIozoCnLOaQZkzqVAtKCKbC0AE663yNq-ra2VytXbHS7l1hUL_xqG08nj3p2HWbrmz2R27y8EDYAUXd2LftXrtXxTjlsZrd3qvkMZmP2YipuedPO16bWi2q1pX-1X8O_wCwL3ru</recordid><startdate>20060131</startdate><enddate>20060131</enddate><creator>Chen, Min</creator><creator>Aprahamian, Charles J</creator><creator>Celik, Ahmet</creator><creator>Georgeson, Keith E</creator><creator>Garvey, W. Timothy</creator><creator>Harmon, Carroll M</creator><creator>Yang, Yingkui</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20060131</creationdate><title>Molecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction</title><author>Chen, Min ; Aprahamian, Charles J ; Celik, Ahmet ; Georgeson, Keith E ; Garvey, W. Timothy ; Harmon, Carroll M ; Yang, Yingkui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a351t-5f8023f92a12716e090ba32d782c889746888e345d07b6570bd69aba8322138c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>alpha-MSH - analogs &amp; derivatives</topic><topic>alpha-MSH - chemistry</topic><topic>alpha-MSH - metabolism</topic><topic>Amino Acid Sequence</topic><topic>Amino Acid Substitution - genetics</topic><topic>Amino Acid Substitution - physiology</topic><topic>Amino Acids, Aromatic - genetics</topic><topic>Amino Acids, Aromatic - metabolism</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Ligands</topic><topic>Melanocyte-Stimulating Hormones - metabolism</topic><topic>Melanocyte-Stimulating Hormones - pharmacology</topic><topic>Membrane Proteins - metabolism</topic><topic>Models, Biological</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Protein Binding - genetics</topic><topic>Protein Binding - physiology</topic><topic>Protein Structure, Tertiary - genetics</topic><topic>Receptor, Melanocortin, Type 3 - antagonists &amp; inhibitors</topic><topic>Receptor, Melanocortin, Type 3 - chemistry</topic><topic>Receptor, Melanocortin, Type 3 - genetics</topic><topic>Receptor, Melanocortin, Type 3 - metabolism</topic><topic>Receptors, Peptide - metabolism</topic><topic>Signal Transduction</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Min</creatorcontrib><creatorcontrib>Aprahamian, Charles J</creatorcontrib><creatorcontrib>Celik, Ahmet</creatorcontrib><creatorcontrib>Georgeson, Keith E</creatorcontrib><creatorcontrib>Garvey, W. Timothy</creatorcontrib><creatorcontrib>Harmon, Carroll M</creatorcontrib><creatorcontrib>Yang, Yingkui</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Min</au><au>Aprahamian, Charles J</au><au>Celik, Ahmet</au><au>Georgeson, Keith E</au><au>Garvey, W. Timothy</au><au>Harmon, Carroll M</au><au>Yang, Yingkui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2006-01-31</date><risdate>2006</risdate><volume>45</volume><issue>4</issue><spage>1128</spage><epage>1137</epage><pages>1128-1137</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Melanocortin-3 receptor (MC3R), primarily expressed in the hypothalamus, plays an important role in the regulation of energy homeostasis. MC3R-deficient (MC3R -/-) mice demonstrate increased fat mass, higher feeding efficiency, hyperleptinaemia, and mild hyperinsulinism. At least one specific mutation of MC3R has been identified to be associated with human obesity. Functional analysis of this altered MC3R (I183N) has indicated that the mutation completely abolishes agonist-mediated receptor activation. However, the specific molecular determinants of MC3R responsible for ligand binding and receptor signaling are currently unknown. The present study is to determine the structural aspects of MC3R responsible for ligand binding and receptor signaling. On the basis of our theoretical model for MC1R, using mutagenesis, we have examined 19 transmembrane domain amino acids selected for these potential roles in ligand binding and receptor signaling. Our results indicate that (i) substitutions of charged amino acid residues E131 in transmembrane domain 2 (TM2), D154 and D158 in TM3, and H298 in TM6 with alanine dramatically reduced NDP-MSH binding affinity and receptor signaling, (ii) substitutions of aromatic amino acids F295 and F296 in TM6 with alanine also significantly decreased NDP-MSH binding and receptor activity, (iii) substitutions of D121in TM2 and D332 in TM7 with alanine resulted in the complete loss of ligand binding, ligand induced receptor activation, and cell surface protein expression, and (iv) interestingly, substitution of L165 in TM3 with methionine or alanine switched antagonist SHU9119 into a receptor agonist. In conclusion:  Our results suggest that TM3 and TM6 are important for NDP-MSH binding, while D121 in TM2 and D332 in TM7 are crucial for receptor activity and signaling. Importantly, L165 in TM3 is critical for agonist or antagonist selectivity. These results provide important information about the molecular determinants of hMC3R responsible for ligand binding and receptor signaling.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>16430209</pmid><doi>10.1021/bi0521792</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2006-01, Vol.45 (4), p.1128-1137
issn 0006-2960
1520-4995
language eng
recordid cdi_crossref_primary_10_1021_bi0521792
source MEDLINE; American Chemical Society Journals
subjects alpha-MSH - analogs & derivatives
alpha-MSH - chemistry
alpha-MSH - metabolism
Amino Acid Sequence
Amino Acid Substitution - genetics
Amino Acid Substitution - physiology
Amino Acids, Aromatic - genetics
Amino Acids, Aromatic - metabolism
Humans
Kinetics
Ligands
Melanocyte-Stimulating Hormones - metabolism
Melanocyte-Stimulating Hormones - pharmacology
Membrane Proteins - metabolism
Models, Biological
Models, Molecular
Molecular Sequence Data
Mutagenesis, Site-Directed
Protein Binding - genetics
Protein Binding - physiology
Protein Structure, Tertiary - genetics
Receptor, Melanocortin, Type 3 - antagonists & inhibitors
Receptor, Melanocortin, Type 3 - chemistry
Receptor, Melanocortin, Type 3 - genetics
Receptor, Melanocortin, Type 3 - metabolism
Receptors, Peptide - metabolism
Signal Transduction
Transfection
title Molecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T07%3A44%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Characterization%20of%20Human%20Melanocortin-3%20Receptor%20Ligand%E2%88%92Receptor%20Interaction&rft.jtitle=Biochemistry%20(Easton)&rft.au=Chen,%20Min&rft.date=2006-01-31&rft.volume=45&rft.issue=4&rft.spage=1128&rft.epage=1137&rft.pages=1128-1137&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi0521792&rft_dat=%3Cacs_cross%3Ec663230359%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16430209&rfr_iscdi=true